Using Smoking Cessation Medications in Patients With Mental Illness
The Carlat Addiction Treatment Report, Volume 10, Number 1, January 2022
Michael Weaver, MD, FASAM.
Professor and medical director at the Center for Neurobehavioral Research on Addictions at the University of Texas Medical School.
Dr. Weaver has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Helping patients with mental illness quit smoking can be particularly challenging; however, there are evidenced based strategies that can help. In this article, we review the evidence for smoking cessation medications in patients with mental illness and highlight some important special considerations.